Galenica successfully places a bond of over CHF 100 million

   Galenica AG / Key word(s): Bond
   Galenica successfully places a bond of over CHF 100 million
   16.04.2024 / 18:05 CET/CEST
     ____________________________________________________________

   
   Press release

   Today, Galenica successfully placed a fixed rate bond of over
   CHF 100 million.

   The bond has a term of 7 years and an annual coupon of 1.65%. The
   proceeds from the transaction will be used for general corporate
   purposes. With this new bond, Galenica is reducing its short-term
   financial liabilities and securing its long-term financing. The
   term until 2031 ideally complements the terms of the outstanding
   bonds from 2026 (CHF 180 million, coupon 1.0%) and 2029
   (CHF 240 million, coupon 2.35%).

   UBS and Zürcher Kantonalbank are joint lead manager for this
   issue. An application for admission to trading on the SIX Swiss
   Exchange for the bond is being made.

   Dates for the diary
   23 May 2024     Galenica Group sales update
   6 August 2024   Galenica Group half-year results 2024
   24 October 2024 Galenica Group sales update

For further information, please contact:

   Media Relations:
   E-Mail: media@galenica.com
   Tel. +41 58 852 85 17 Investor Relations:
   E-Mail: investors@galenica.com
   Tel. +41 58 852 85 31

   Welcome to the Galenica network!
   Our ambition is to meet the needs of patients and customers in
   the Swiss healthcare market in a seamless, efficient and
   personalised way. To achieve this, we operate the Galenica
   network with over 20 Business Units, the strongest partners in
   the Swiss healthcare market. We offer fully integrated solutions
   both for customers and patients as well as for pharmacies,
   drugstores, medical practices, hospitals, retirement and nursing
   homes, home care providers, wholesalers, pharmaceutical
   companies, health insurance funds and other partners.
   Galenica is listed on the Swiss Stock Exchange (SIX Swiss
   Exchange, GALE, security number 36,067,446). Additional
   information concerning Galenica can be found at www.galenica.com.

____________________________________________________________

   End of Media Release
     ____________________________________________________________

   Language:    English
   Company:     Galenica AG
                Untermattweg 8
                3027 Bern
                Switzerland
   Phone:       +41 058 852 81 11
   E-mail:      info@galenica.com
   Internet:    https://www.galenica.com
   ISIN:        CH0360674466
   Listed:      SIX Swiss Exchange
   EQS News ID: 1881579

   End of News EQS News Service
     ____________________________________________________________

1881579 16.04.2024 CET/CEST